---
title: Respiratory Physiology
order: 2
category: Physiology
status: complete
last_updated: '2025-01-09'
---

# Respiratory Physiology

## Overview

The respiratory system facilitates gas exchange between the atmosphere and blood, maintaining oxygen delivery and carbon dioxide removal. The system consists of conducting airways (nose to terminal bronchioles) and respiratory zones (respiratory bronchioles to alveoli). Primary functions include ventilation, gas exchange, acid-base balance, defense mechanisms, and metabolic functions.

### Respiratory Anatomy

**Upper Respiratory Tract**:
- Nose/mouth: Air filtration, humidification, warming
- Pharynx: Shared pathway for air and food
- Larynx: Voice production, airway protection
- Trachea: Main conducting airway

**Lower Respiratory Tract**:
- Bronchi: Main airways with cartilage support
- Bronchioles: Smaller airways, smooth muscle control
- Alveoli: Gas exchange units (~300 million)

**Respiratory Muscles**:
- **Inspiration**: Diaphragm (primary), external intercostals, accessory muscles
- **Expiration**: Passive at rest, internal intercostals and abdominal muscles during forced expiration

## Pathophysiology

### Ventilation Mechanics

**Lung Volumes and Capacities**:
- **Tidal Volume (TV)**: 500 mL (normal breathing)
- **Inspiratory Reserve Volume (IRV)**: 3000 mL
- **Expiratory Reserve Volume (ERV)**: 1100 mL
- **Residual Volume (RV)**: 1200 mL
- **Functional Residual Capacity (FRC)**: ERV + RV = 2300 mL
- **Vital Capacity (VC)**: TV + IRV + ERV = 4600 mL
- **Total Lung Capacity (TLC)**: VC + RV = 5800 mL

**Pressure Relationships**:
- **Atmospheric Pressure (Patm)**: 760 mmHg at sea level
- **Intrapleural Pressure (Pip)**: -4 mmHg at rest
- **Transpulmonary Pressure**: Palveolar - Pip
- **Transmural Pressure**: Determines airway patency

### Gas Exchange

**Diffusion Process**:
- Governed by Fick's Law: Rate ∝ (Area × Solubility × ΔP) / (Thickness × √MW)
- Alveolar-capillary membrane: 0.5 μm thick
- Surface area: ~70 m² in healthy adults

**Oxygen Transport**:
- **Dissolved O₂**: 1.5% (PaO₂ × 0.003)
- **Hemoglobin-bound O₂**: 98.5% (1.34 mL O₂/g Hb)
- **Oxygen Content**: CaO₂ = (Hb × SaO₂ × 1.34) + (PaO₂ × 0.003)

**Oxygen-Hemoglobin Dissociation Curve**:
- Sigmoid shape, P₅₀ = 27 mmHg
- **Right shift** (decreased affinity): ↑PCO₂, ↑H⁺, ↑temperature, ↑2,3-DPG
- **Left shift** (increased affinity): ↓PCO₂, ↓H⁺, ↓temperature, CO poisoning

**Carbon Dioxide Transport**:
- **Dissolved CO₂**: 7% (PCO₂ × 0.067)
- **Carbaminohemoglobin**: 23%
- **Bicarbonate**: 70% (CO₂ + H₂O ↔ H₂CO₃ ↔ H⁺ + HCO₃⁻)

### Ventilation-Perfusion Relationships

**V/Q Ratio**:
- Normal V/Q = 0.8 (alveolar ventilation 4 L/min, cardiac output 5 L/min)
- **V/Q = 0**: Shunt (perfusion without ventilation)
- **V/Q = ∞**: Dead space (ventilation without perfusion)
- **V/Q mismatch**: Primary cause of hypoxemia

**Regional V/Q Variations**:
- Base of lung: V/Q = 0.6 (high perfusion)
- Apex of lung: V/Q = 3.0 (high ventilation)

### Control of Breathing

**Respiratory Centers**:
- **Medullary centers**: Automatic breathing
  - Pre-Bötzinger complex: Respiratory rhythm generator
  - Ventral respiratory group: Inspiration and expiration
  - Dorsal respiratory group: Integration center

- **Pontine centers**: Breathing pattern modification
  - Pneumotaxic center: Fine-tuning
  - Apneustic center: Prolonged inspiration

**Chemical Control**:
- **Central chemoreceptors** (medulla): Respond to CSF pH (reflects PCO₂)
- **Peripheral chemoreceptors** (carotid/aortic bodies): Respond to PO₂, PCO₂, pH

**Hypoxic Drive**:
- Activated when PaO₂ < 60 mmHg
- Primary driver in chronic hypercapnia (COPD)

## Clinical Presentation

### Pulmonary Function Tests

**Spirometry**:
- **FEV₁**: Forced expiratory volume in 1 second
- **FVC**: Forced vital capacity
- **FEV₁/FVC ratio**: <0.70 suggests obstruction

**Flow-Volume Loops**:
- **Obstructive pattern**: Scooped appearance, reduced peak flow
- **Restrictive pattern**: Reduced volumes, normal shape

**Lung Volumes**:
- **Restrictive diseases**: ↓TLC, ↓VC, ↓FRC
- **Obstructive diseases**: ↑TLC, ↑FRC, ↑RV

### Arterial Blood Gas Analysis

**Normal Values**:
- pH: 7.35-7.45
- PaCO₂: 35-45 mmHg
- PaO₂: 80-100 mmHg
- HCO₃⁻: 22-28 mEq/L
- SaO₂: >95%

**Acid-Base Disorders**:
- **Respiratory acidosis**: ↓pH, ↑PCO₂
- **Respiratory alkalosis**: ↑pH, ↓PCO₂
- **Metabolic acidosis**: ↓pH, ↓HCO₃⁻
- **Metabolic alkalosis**: ↑pH, ↑HCO₃⁻

**Oxygenation Assessment**:
- **Hypoxemia**: PaO₂ < 80 mmHg
- **A-a gradient**: PAO₂ - PaO₂ (normal <15 mmHg)
- **P/F ratio**: PaO₂/FiO₂ (normal >400)

## Diagnosis

### Respiratory Mechanics

**Compliance**: Change in volume per unit pressure change
- **Lung compliance**: 200 mL/cmH₂O
- **Chest wall compliance**: 200 mL/cmH₂O
- **Total compliance**: 100 mL/cmH₂O (1/Ctotal = 1/Clung + 1/Cchest)

**Resistance**: Opposition to airflow
- **Poiseuille's Law**: R ∝ 1/r⁴
- Normal airway resistance: 1-2 cmH₂O/L/sec

**Work of Breathing**:
- **Elastic work**: Overcoming lung and chest wall compliance
- **Resistive work**: Overcoming airway resistance
- Increased in respiratory disease

### Gas Exchange Assessment

**Alveolar Gas Equation**:
PAO₂ = (FiO₂ × [Patm - PH₂O]) - (PaCO₂/RQ)
- At sea level, room air: PAO₂ = (0.21 × 713) - (40/0.8) = 100 mmHg

**Shunt Equation**:
Qs/Qt = (CcO₂ - CaO₂)/(CcO₂ - CvO₂)
- Normal shunt: <5%

**Dead Space Equation**:
VD/VT = (PaCO₂ - PECO₂)/PaCO₂
- Normal: 20-30% of tidal volume

## Treatment

### Oxygen Therapy

**Indications**:
- PaO₂ < 60 mmHg or SaO₂ < 90%
- Acute hypoxemia
- Carbon monoxide poisoning

**Delivery Systems**:
- **Low-flow devices**: Nasal cannula (24-40% FiO₂), simple mask
- **High-flow devices**: Venturi mask, non-rebreather mask
- **High-flow nasal cannula**: Up to 60 L/min, 100% FiO₂

### Mechanical Ventilation

**Indications**:
- Respiratory failure (PaO₂ < 60 mmHg, PaCO₂ > 50 mmHg)
- Airway protection
- Excessive work of breathing

**Ventilator Modes**:
- **Volume control**: Set tidal volume delivered
- **Pressure control**: Set pressure delivered
- **PEEP**: Positive end-expiratory pressure prevents alveolar collapse

**Ventilator Settings**:
- **FiO₂**: Start 100%, wean to <60%
- **PEEP**: 5-15 cmH₂O
- **Respiratory rate**: 12-20/min
- **Tidal volume**: 6-8 mL/kg ideal body weight

### Respiratory Pharmacology

**Bronchodilators**:
- **β₂-agonists**: Albuterol, salmeterol (relax smooth muscle)
- **Anticholinergics**: Ipratropium, tiotropium (block parasympathetic)
- **Methylxanthines**: Theophylline (phosphodiesterase inhibition)

**Anti-inflammatory**:
- **Corticosteroids**: Prednisolone, budesonide
- **Leukotriene modifiers**: Montelukast
- **Mast cell stabilizers**: Cromolyn sodium

## Complications

### Respiratory Failure

**Type I (Hypoxemic)**:
- PaO₂ < 60 mmHg with normal or low PaCO₂
- Causes: Pneumonia, ARDS, pulmonary edema
- Mechanism: V/Q mismatch, shunt

**Type II (Hypercapnic)**:
- PaCO₂ > 50 mmHg with acidemia
- Causes: COPD exacerbation, neuromuscular disease
- Mechanism: Hypoventilation

### Acute Respiratory Distress Syndrome (ARDS)

**Berlin Definition**:
- Acute onset (<1 week)
- Bilateral pulmonary infiltrates
- P/F ratio <300
- Not fully explained by heart failure

**Pathophysiology**:
- Diffuse alveolar damage
- Increased capillary permeability
- Hyaline membrane formation

### Ventilator-Induced Lung Injury (VILI)

**Mechanisms**:
- **Volutrauma**: Overdistension injury
- **Atelectrauma**: Repeated opening/closing
- **Biotrauma**: Inflammatory response
- **Barotrauma**: High pressure injury

**Prevention**:
- Low tidal volume ventilation (6 mL/kg)
- Adequate PEEP
- Pressure limitation

## Prognosis

### Respiratory Disease Severity

**COPD Staging** (GOLD criteria):
- **Mild**: FEV₁ ≥80% predicted
- **Moderate**: 50% ≤ FEV₁ < 80%
- **Severe**: 30% ≤ FEV₁ < 50%
- **Very severe**: FEV₁ < 30%

**Asthma Control**:
- **Well-controlled**: Symptoms ≤2 days/week
- **Not well-controlled**: Symptoms >2 days/week
- **Very poorly controlled**: Symptoms daily

### Predictors of Respiratory Failure

**Risk Factors**:
- Age >65 years
- Comorbidities (heart failure, diabetes)
- Baseline hypercapnia
- Pneumonia severity scores

**Weaning Predictors**:
- **Rapid shallow breathing index**: f/VT <105
- **Maximum inspiratory pressure**: <-20 cmH₂O
- **Spontaneous breathing trial**: 30-120 minutes

## Key Points

1. **Ventilation** is driven by pressure gradients created by respiratory muscle contraction and elastic recoil

2. **Gas exchange** depends on ventilation-perfusion matching, with V/Q mismatch being the most common cause of hypoxemia

3. **Oxygen transport** relies primarily on hemoglobin binding, with the oxygen-hemoglobin dissociation curve shape facilitating both loading and unloading

4. **Control of breathing** involves both automatic (medullary) and voluntary (cortical) components, with chemical feedback from CO₂ being the primary driver

5. **Pulmonary function tests** differentiate obstructive (↓FEV₁/FVC) from restrictive (↓TLC) patterns

6. **Arterial blood gases** provide essential information about ventilation (CO₂), oxygenation (O₂), and acid-base status

7. **Respiratory failure** is classified as hypoxemic (Type I) or hypercapnic (Type II) with different underlying mechanisms

8. **Mechanical ventilation** should use lung-protective strategies to minimize ventilator-induced lung injury

## References

1. West JB, Luks AM. West's Respiratory Physiology: The Essentials. 10th ed. Philadelphia: Wolters Kluwer; 2016.
2. Levitzky MG. Pulmonary Physiology. 9th ed. New York: McGraw-Hill; 2018.
3. Wagner PD. The physiological basis of pulmonary gas exchange: implications for clinical interpretation of arterial blood gases. Eur Respir J. 2015;45(1):227-243.
4. ARDS Definition Task Force. Acute respiratory distress syndrome: the Berlin Definition. JAMA. 2012;307(23):2526-2533.
5. Global Initiative for Chronic Obstructive Lung Disease. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease. 2023 Report.
